How do I account for a modification — such as repricing or accelerating vesting — of a share-based payment under IFRS 2?

Core Rule When the terms of an equity-settled award are modified, an entity must recognise, at a minimum, the services received measured at the original grant-date fair value. If the modification increases the total fair value or is otherwise beneficial to the employee, recognise the incremental fair value over the remaining vesting period. If the modification decreases fair value (i.e., is detrimental), ignore it for accounting purposes and continue as if the original terms still apply (IFRS 2.26–27). What Counts as a Modification? A modification is any change to the terms or conditions of a share-based payment arrangement. Common examples: - Repricing: reducing the exercise price of underwater options (e.g., from €30 to €18 when the share price has fallen to €15). - Extension of vesting period: giving employees more time to satisfy performance conditions. - Acceleration of vesting: waiving the remaining vesting period (often on termination without cause or in a change of control). - Additional awards: granting incremental shares or options on top of the original award. - Change in settlement: converting an equity-settled award to a cash payment. - Relaxation of performance conditions: making it easier to meet the target. Beneficial vs Detrimental Modifications The accounting treatment depends on whether the modification benefits the employee: | Type | Effect on fair value | Accounting | |---|---|---| | Beneficial (e.g., repricing) | Increases FV | Recognise original grant-date FV + incremental FV | | Neutral | No

How do I calculate the incremental fair value when repricing underwater share options under IFRS 2?

change in FV | Continue recognising original grant-date FV | | Detrimental (e.g., increasing exercise price) | Decreases FV | Ignore — continue on original terms | Incremental fair value = fair value of modified award immediately after modification − fair value of original award immediately before modification. The incremental fair value is spread over the remaining vesting period from the modification date. Acceleration of Vesting When vesting is accelerated — for example, on a change of control or on termination — the entity must recognise immediately all remaining expense that would otherwise have been recognised over the original vesting period. The unrecognised grant-date fair value is charged to profit or loss at the acceleration date, with a corresponding credit to equity. Cash Settlement of an Equity Award (IFRS 2.41) If an equity-settled award is cancelled and replaced with a cash payment, the entity: 1. Recognises the cash payment as the repurchase of an equity interest — debit the equity reserve up to the fair value of the equity instrument at the repurchase date. 2. Any excess cash paid above the fair value of the equity instrument at the repurchase date is recognised as an expense in profit or loss. 3. No incremental fair value calculation — this is treated as a cancellation and new cash-settled transaction. Worked Example — Repricing Original grant: 5,000 options, exercise price €30, grant-date FV €6, 4-year vesting, 2 years remaining. Situation: after 2 years the share price has fallen to €14. The com

If share options are cancelled without replacement, do I reverse the IFRS 2 expense already recognised?

pany reprices the options to €16. Step 1 — Fair value immediately before repricing (original terms, share price €14): €1.20 per option. Step 2 — Fair value immediately after repricing (new exercise price €16, share price €14): €3.50 per option. Step 3 — Incremental fair value: €3.50 − €1.20 = €2.30 per option. Step 4 — Remaining expense schedule: | Period | Original grant-date FV (remaining) | Incremental FV | Total charge | |---|---|---|---| | Remaining 2 years | 5,000 × €6 × 2/4 = €15,000 | 5,000 × €2.30 × 2/2 = €11,500 | €26,500 | | Per year | €7,500 | €5,750 | €13,250 | Year-end journal entry (each of the 2 remaining years): | Account | Dr (€) | Cr (€) | |---|---|---| | Share-based payment expense | 13,250 | | | Share-based payment reserve (Equity) | | 13,250 | Worked Example — Acceleration on Termination Setup: Employee holds 1,000 RSUs, grant-date FV €40, 3-year vesting. The employee is made redundant at end of year 1 with immediate vesting of all awards. Expense recognised in year 1 (before acceleration): 1,000 × €40 × 1/3 = €13,333. Remaining unrecognised: 1,000 × €40 × 2/3 = €26,667. Acceleration journal entry at termination: | Account | Dr (€) | Cr (€) | |---|---|---| | Share-based payment expense | 26,667 | | | Share-based payment reserve (Equity) | | 26,667 | Total recognised: €40,000 = full grant-date fair value, consistent with full vesting. Cancellation Without Replacement (IFRS 2.28) If an award is cancelled outright (not replaced, not cash-settled): - Recognise immediately the remaining unrecognised

What happens to the IFRS 2 expense when an employee is made redundant and options vest immediately?

grant-date fair value that would have been recognised over the remainder of the vesting period. - Any amounts already recognised in equity remain in equity — they are not reversed. This treatment is identical to the acceleration of vesting — cancellation accelerates the expense, it does not eliminate it. Common Pitfalls - Applying modification accounting to market-condition failures: if the share price falls below a hurdle, this is not a modification — the original terms remain in force. Only deliberate changes by the entity or employee constitute a modification. - Ignoring detrimental modifications: increasing the exercise price or adding performance conditions reduces fair value but must be ignored for accounting purposes. Continue on original terms. - Calculating incremental fair value on the wrong date: incremental fair value is measured immediately before and after the modification date — not at the original grant date vs the modification date. - Reversing equity on cancellation: IFRS 2.28 requires immediate recognition of remaining expense on cancellation, not reversal. The equity credit stays; the P&L takes the accelerated hit. Key Paragraphs - IFRS 2.26 — modification: minimum recognition at original grant-date FV - IFRS 2.27 — beneficial modification: recognise incremental fair value - IFRS 2.28 — cancellation: treat as accelerated vesting, recognise remaining expense immediately - IFRS 2.41 — cash settlement of equity award: debit equity reserve, excess to P&L - IFRS 2 Appendix A — definition of modificat

IFRS 2 Modification and Cancellation of Share-Based Payments — Repricing Guide

IFRS 2 Modification and Cancellation of Share-Based Payments — Core Rule

When the terms of an equity-settled award are modified, an entity must recognise, at a minimum, the services received measured at the original grant-date fair value. If the modification increases the total fair value or is otherwise beneficial to the employee, recognise the incremental fair value over the remaining vesting period. If the modification decreases fair value (i.e., is detrimental), ignore it for accounting purposes and continue as if the original terms still apply (IFRS 2.26–27).

What Counts as a Modification?

A modification is any change to the terms or conditions of a share-based payment arrangement. Common examples: